ArticleThe Journal of international medical research2026
Triglyceride-cholesterol-body weight index and microvascular complications in Tibetan adults with type 2 diabetes: A cross-sectional study.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo examine the associations of the triglyceride-cholesterol-body weight index with microvascular complications and assess its incremental value beyond conventional variables and its components.MethodsThis cross-sectional study included Tibetan adults with type 2 diabetes from the China National Diabetic Chronic Complications Study. Logistic regression and restricted cubic spline analyses were used to evaluate the associations of triglyceride-cholesterol-body weight index with albuminuria, reduced estimated glomerular filtration rate, and diabetic retinopathy. Triglyceride-cholesterol-body weight index was compared with triglycerides, total cholesterol, body weight, body mass index, and the Castelli risk indices. The incremental predictive value of albuminuria was assessed using the 10-fold cross-validated area under the receiver operating characteristic curve, Brier score, and calibration slope. A sensitivity analysis excluded patients receiving lipid-lowering medications.ResultsAmong 662 participants, 657 contributed to the renal analyses and 575 to the retinopathy analyses. The prevalence of albuminuria increased from 40.0% in the lowest quartile to 54.9% in the highest quartile. After full adjustment, triglyceride-cholesterol-body weight index was not associated with albuminuria (odds ratio per 1-standard deviation increase, 1.09; 95% confidence interval: 0.91-1.32; p = 0.355), reduced estimated glomerular filtration rate, or diabetic retinopathy. Spline analyses showed no evidence of nonlinearity. Adding triglyceride-cholesterol-body weight index changed the cross-validated area under the receiver operating characteristic curve from 0.728 to 0.725 and did not improve the Brier score or calibration slope. Triglyceride-cholesterol-body weight index provided no improvement beyond its components. Excluding patients receiving lipid-lowering medications yielded a similar estimate for albuminuria (odds ratio = 1.10; 95% confidence interval: 0.91-1.34).ConclusionsTriglyceride-cholesterol-body weight index reflected a metabolic profile but was not independently associated with microvascular outcomes. No incremental value beyond conventional clinical variables and its components was demonstrated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.